Categories Dermatology -Adelphi Values PRO gap analysis and competitor review in acne vulgaris PRO development in acne vulgaris Concept elicitation interviews in acne vulgaris to reach saturation Observational psychometric validation study in acne vulgaris Single item validation and user’s manual in acne vulgaris Mixed method evaluation of an acne vulgaris measure – racial equivalence in non-Caucasion subjects using existing data Medical writing for development and validation of a PRO in acne vulgaris Clinical outcome assessments in acne scars Literature research and content validation in acne scars Analysis, reporting and patient interviews PRO in acne vulgaris PRO instrument review in acne Content validity testing of and regulatory support for use of the PRE-FACE in acne vulgaris Linguistic validation and translation of the PRE-FACE Literature review and stakeholder interviews on payer decision drivers in actinic keratosis Statistical analysis and data interpretation from a multinational observational study in actinic keratosis Manuscripts on a treatment for actinic keratosis Patient diary study and analyses in actinic keratosis Reporting on a patient diary study on adherence to topical treatment in actinic keratosis Update of a dossier and development of a value story slide set to support affiliate teams in the value of an actinic keratosis product Update to a core value dossier and value messages on actinic keratosis Communication of PRO analysis from a phase III trial in actinic keratosis Communication tool and materials on treatment in actinic keratosis Publication summaries on treatment for actinic keratosis Reimbursement dossier for a treatment in actinic keratosis Use of PROs and ClinROs to build the best evidence and optimise market access for actinic keratosis Gap analysis of PROs for the use of a drug to grow darker and longer hair on the scalp Conference poster on a gap analysis in alopecia Development and validation of a photographic assessment and symptom measure in alopecia Development of a symptom and impact PRO in alopecia Development of a treatment satisfaction module for alopecia Brief statistical analysis synthesis and interpretation (photo guide) in alopecia Patient interviews for the development of alopecia-related PRO measures Observational psychometric validation study in alopecia Dossier on PRO measures in alopecia PRO dossier for Subject Self-Assessment of Alopecia (SSAA) Observational psychometric testing study in alopecia Single item analysis in alopecia Development of PRO and ClinRO instruments for alopecia totalis and alopecia universalis Review and provide input into the development of a data analysis plan, validation study, drafts and final report of a randomized controlled trial on alopecia medicine Conceptual equivalence testing of alopecia ePROs Cognitive debriefing of the revised Subject Self-Assessment (SSA) and Hair Growth Questionnaire (HGQ) with patients with androgenic alopecia Psychometric analyses and regulatory support in the development of PRO and ClinRO instruments for alopecia areata patchy, universalis and totalis Mini value dossier in atopic dermatitis Payer value materials in atopic dermatitis Product value insight evaluation and strategy in atopic dermatitis Core value dossier in atopic dermatitis Analysis of the impact of chronic hand dermatitis on work productivity among healthcare workers in the UK COA consulting support for a numeric rating scale in pruritus Preparation of qualitative data in atopic dermatitis for FDA submission Translation and linguistic validation of the numerical rating scale (NRS) in pruritus and cognitive debriefing of an ePRO diary Development of a symptom-based PRO instrument in atopic dermatitis Development of a PRO in adult atopic dermatitis Psychometric evaluation of PROs in adult atopic dermatitis COA development and content validity in atopic dermatitis Development of a manuscript to communicate the patient experience of atopic dermatitis Regulatory support in adolescent atopic dermatitis Development and cognitive debriefing of a symptom diary for use in adults and adolescents with atopic dermatitis Two abstracts to communicate the development of the atopic dermatitis adult and adolescent conceptual models Usability testing of electronic handheld numeric rating scale (NRS) items in atopic dermatitis Linguistic validation and translation of the PRE-FACE Relationship between clinical outcome assessment (COAs) and objective measures in atopic dermatitis and sleep Literature review in dystrophic epidermolysis bullosa (DEB) Literature review to identify the chronic hand eczema population in the US Regulatory support in chronic hand eczema Development of a manuscript to communicate the patient experience of chronic hand eczema Two abstracts to communicate the development of a conceptual model in chronic hand eczema Development and validation of a questionnaire to assess patient’s satisfaction with treatment for oily skin (excess sebum) Validation of the Excess Sebum Treatment Satisfaction Scale and the Patient Reported Excess Sebum Co-primary efficacy endpoint Focus group sessions presentation on excess sebum Cognitive debriefing interviews in excess sebum Consultation on a methods study to validate primary and secondary endpoint measures in excess sebum Initial psychometric validation of an oily skin questionnaire Face and content validation of the oily skin PRO instruments in adolescents Development of a poster and manuscript for the validation of an eyelash satisfaction questionnaire in China Development of an EMA PRO dossier for an eyelash satisfaction questionnaire Validation of the EEM and ESS in eyelash hypotrichosis Item-level validation for a questionnaire in eyelash health and satisfaction Validation of the eyelash satisfaction questionnaire in Japan Development of a PRO dossier for the 9-item eyelash satisfaction questionnaire for Japan Translation and validation of an eyelash questionnaire in China Gap analysis of PROs for the use of a drug to grow darker and longer eyebrows Content testing and adaptation of the eyelash satisfaction questionnaire (ESQ-9) for eyebrows Cognitive interviews on the eyebrow satisfaction questionnaire User manual and single item validation in eyebrow satisfaction Qualitative interviews to evaluate the psychological impact of the brow satisfaction questionnaire and to validate in a post-chemotherapy population Development and validation of a PRO measure in facial lines Validation plan and FDA regulatory support for the Facial Wrinkling Scale Poster production for two PRO measures of facial wrinkling to be presented at a dermatological conference Development of a manuscript to report the results of a PRO measure in facial wrinkling Validation of a PRO measure of facial line satisfaction Qualitative interviews to support the concept of psychological impact on the facial line outcomes questionnaire Cognitive interviews in facial line satisfaction Validation of the subject facial wrinkle scale in China Psychometric evaluation of a PRO in facial lines Support in securing advice on marketing claims not currently in the FDA-approved product label for a cosmetic treatment for facial lines FDA dossier on a cosmetic treatment for facial lines EMA dossier on a cosmetic treatment for facial lines Content validation of the subject-rated facial wrinkle scale for forehead lines Cognitive debriefing of a ClinRO in facial lines Cognitive debriefing of a PRO in facial lines Validation of a skin / wrinkling module Validation of questionnaires for facial lines in Japan Validation of questionnaires for facial lines in China Consulting for ClinROs and PROs in facial lines and hyperhidrosis Content validation of the facial wrinkle scale Review of PRO endpoints for use of a topical botulinum toxin in trials for the treatment of crow’s feet Development of a PRO briefing document to support the facial wrinkling scale in crow’s feet Qualitative analysis of patient interviews to identify how subjects describe the severity of crow’s feet Cognitive debriefing of a PRO in glabellar lines Preparation of a payer briefing document for a treatment for glabellar facial lines Abstract and poster development for a glabellar line clinical program Support in the linguistic validation of glabellar facial line PROs Publication strategy of PROs in glabellar lines Psychometric evaluation and regulatory strategy of PROs in glabellar lines Consulting agreement for trial preparation and PRO endpoints in canthal lines Evaluation of psychological impact using the facial lines outcome-11 questionnaire in forehead lines, glabellar lines and upper facial lines Prescription Drug Marketing Act (PMDA) PRO dossier for a cosmetic program Core value dossier to support new treatment in hidradenitis suppurativa Update to a value proposition deck with adolescent data in hidradentis suppurativa Core value dossier, payer value proposition and objection handler update in hidradenitis suppurativa Structured literature review and value dossier updates in a biosimilar for hidradenitis suppurativa Payer value deck for a biosimilar in hidradenitis suppurativa Development and validation of a PRO tool in hidradenitis suppurativa Measurement of pain in hidradenitis suppurativa Development of a PRO in hidradenitis suppurativa Development of an investigator training manual in hidradenitis suppurativa Development of FDA response on phase II hidradenitis suppurativa study protocol Poster for a PRO in hidradenitis suppurativa Mechanism of Action (MOA) Equivalency Testing in hidradenitis suppurativa Clinical endpoint guidance and observational study in hidradenitis suppurativa ClinRO inter-rater reliability study in hidradenitis suppurtiva Design, placement and placement of outcomes in registry for hidradenitis suppurativa HEOR strategic consulting in hidradenitis suppurativa Pre- and post-surgery research study in hidradenitis suppurativa Development of three measurement dossiers in hidradenitis suppurativa to support regulatory submissions Psychometric testing of the Hidradenitis Suppurativa Impact Assessment (HSIA) and Hidradenitis Suppurativa Symptom Assessment (HSSA) Summary report and publications for hidradenitis suppurativa pain and relevant tools Evaluating the clinical meaning of defining treatment response based on the Hidradenitis Suppurativa Clinical Response (HiSCR) Statistical analyses of registry data (UNITE) in hidradenitis suppurativa Literature review on hidradenitis suppurativa Review article on adherence to topical therapies in dermatological conditions HTA and reimbursement surveillance in dermatology Biosimilar payer communications in dermatology Literature and content searches for global value dossiers in dermatology Psychometric evaluation of a PRO in hyperhidrosis Development of a PRO and ClinRo for use in prurigo nodularis Development and validation of a ClinRO to measure changes in peristomal skin Global value dossier for a treatment for tissue management Development and translation of a 6 item dermatology questionnaire into Danish EMA dossier and literature review support in dermatology Development and validation of the Skin Infection Rating Scale (SIRS) Strategic review and recommendations for paediatric endpoints to assess pruritis in colostatic liver disease Translation and linguistic validation of the numerical rating scale (NRS) in pruritus and cognitive debriefing of an ePRO diary COA consulting support for a numeric rating scale in pruritus Development of a payer value proposition and materials in psoriasis NICE submissions for a new biologic for the treatment of moderate to severe psoriasis in the UK Systematic literature review of quality of life in psoriasis Manuscript on a literature review of quality of life in psoriasis Literature review and stakeholder interviews on payer decision drivers in psoriasis Update a to core value dossier in psoriasis UK value story for a new treatment in psoriasis vulgaris Competitor review deck and objection handler in psoriasis Mini competitor review for a value proposition in psoriasis Budget impact model for a new treatment in psoriasis vulgaris Systematic literature review and network meta-analysis update in psoriasis Indirect treatment comparison for a 2nd round response to PBAC for a psoriasis treatment Supplementary analyses and reporting for the psoriasis network meta-analysis Payer evidence dossier for a new psoriasis treatment Payer dossier on psoriasis Payer dossier for paediatric psoriasis Mini value dossier on paediatric psoriasis Repurposing a slide deck for a payer value proposition in paediatric psoriasis Core value dossier/payer value deck updates and competitor value differentiation slide sets on psoriasis Core value dossier, payer value proposition and objection handler in psoriasis Update to a value proposition slide deck for a treatment in psoriasis Core value dossier update in psoriasis Systematic literature review and network analysis in psoriasis Early global value dossiers for a new monoclonal antibody in psoriasis Total Brand FAQ deck and Total Brand Workshop in psoriasis Global value dossiers and budget impact models for biosimilars in psoriasis Systematic literature review in psoriasis – update for Poland Targeted literature review in psoriatic arthritis patients with concomitant moderate to severe psoriasis Country adaptation of a European payer dossier in psoriasis to Latin America and Spain Core value dossier, value deck, literature review and objection handler in psoriasis Global value dossier update in paediatric psoriasis Structured literature review and value dossier updates in a biosimilar for psoriasis and paediatric plaque psoriasis Budget impact model on the costs of treating psoriasis Payer value deck for a biosimilar in psoriasis and paediatric plaque psoriasis Psychometric testing of self-assessment of a psoriasis symptoms questionnaire Psychometric validation of a psoriasis tool Analysis and Abstract Development on a cumulative life course impairment (CLCI) in psoriasis CLCI marketing and clinical data analysis of a psoriasis tool Development of a PRO to assess sexual dysfunction in psoriasis Development of a poster to describe the development of a PRO to assess the impacts of psoriasis Scientific communications on the development of a PRO to assess sexual dysfunction in psoriasis Development of psoriasis symptoms and treatment satisfaction measures Patient preference study in plaque psoriasis Strategic PRO review in psoriasis Interviews with patient focus groups in psoriasis Database analysis and publications in psoriasis treatment Review of PROs and preparation and writing of a PRO briefing document for the FDA on the treatment of psoriasis Review of a briefing document prepared for submission to the FDA in support of labelling claims in psoriasis Briefing book support and psychometric evaluation of the Self-Assessment for Psoriasis Symptoms (SAPS) International economic evaluation of a treatment for moderate to severe chronic plaque psoriasis Measurement strategy in chronic plaque psoriasis Support in development and analyses of a patient support programme in plaque psoriasis Manuscript on Self-Assessment for Psoriasis Symptoms (SAPS) psychometric publications Development of a symptom, impact and satisfaction measure in rosacea Testing PRO measures in electronic devices for rosacea Development of a photonumeric guide for rosacea Patient interviews and reporting on a photoguide in rosacea Cognitive photoguide interviews in rosacea SAP development for phase II psych testing in rosacea Simultaneous development and regulatory documentation of two PRO questionnaires to assess the signs and symptoms of interdigital tinea pedis and rosacea Development of a PRO dossier for the Subject Self-Assessment of Erythema Scale (SSA) for erythematous rosacea Linguistic validation and translation of the PAPSS, PAPI, PGIS, PGI-C, PGI-TS and PGI-SE in rosacea Psychometric validation and field study on the Patient-Reported Scar Evaluation Questionnaire (PR-SEQ) Regulatory consulting and attendance at an FDA meeting for the PR-SEQ Translation and linguistic validation of the PR-SEQ Consulting on patient qualitative insight blogs with follow-up interviews to explore wound scar healing Development of a photonumeric guide and PRO measure of surgical scarring Sub-group analysis of scar data Development of PRO instruments for anterior and posterior peri-axillary fat Content validity testing of the lower facial shape questionnaire and regulatory support End of phase II regulatory support for PRO endpoints in submental fat Analytic and strategic support in cosmetic/submental fat Non-parametric statistics PRO endpoints on cosmetic surgery on the chin Revisions of a photonumeric scale in centralized abdominal bulging Content validity of PROs in submental subcutaneous fat Development of a paediatric, adolescent and adult QoL measure of viral warts ClinRO development for common warts Development, evaluation, and regulatory support for the Physician Wart Assessment Cookies Policy